Identifying Early Predictive Markers for Immune-Related Adverse Events in Nivolumab-Treated Patients with Renal Cell Carcinoma and Gastric Cancer.
Asian Pacific journal of cancer prevention : APJCP（2022）
摘要
NLR is an effective marker for prognosis and onset of grade 3-4 irAEs.
更多查看译文
关键词
Immune checkpoint inhibitors,Neutrophils to lymphocytes,immune-related adverse event,platelet to lymphocytes
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要